250 Participants Needed

ADELANTE for HIV

Recruiting at 1 trial location
JH
Overseen ByJulie H Levison, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
Must be taking: Antiretrovirals
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to test whether a new program called ADELANTE (a Community Health Worker-Delivered Problem-Solving Intervention) can help Latino individuals with HIV manage their condition more effectively. Participants will either engage in five problem-solving sessions with a community health worker or receive five reminder calls as part of enhanced care. The study will compare the effectiveness of each approach in controlling the virus and reducing hospital visits. Ideal candidates are Latino adults with HIV who have struggled to suppress the virus despite treatment. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance HIV management strategies for the Latino community.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on a behavioral intervention rather than medication changes.

What prior data suggests that the ADELANTE intervention is safe for participants?

Research has shown that programs like ADELANTE, which use community health workers (CHWs), are well-received by people living with HIV. These programs involve trained workers who offer support and education. They are generally safe and carry low risks. Studies often find that participants have positive experiences with CHW programs. These programs can improve health without causing major side effects, and no reports of serious problems have emerged. By focusing on problem-solving and providing personalized support, these programs prove helpful and satisfying to most participants.12345

Why are researchers excited about this trial?

Researchers are excited about the ADELANTE treatment for HIV because it offers a unique, community-focused approach. Unlike standard HIV treatments that primarily rely on medication, ADELANTE provides personalized problem-solving sessions through community health workers. This method is complemented by a bilingual film about HIV, which makes the sessions more relatable and culturally sensitive. This innovative approach aims to improve patient engagement and adherence to care by addressing individual challenges and cultural contexts, which could lead to better health outcomes for people living with HIV.

What evidence suggests that the ADELANTE intervention could be effective for viral suppression in Latinos with HIV?

Research has shown that programs like ADELANTE, which involve community health workers, can improve health outcomes for people with HIV. In this trial, participants in the ADELANTE arm will attend five problem-solving sessions led by community health workers, using engaging materials such as a bilingual film about HIV to connect with participants. People in similar programs have been more likely to stay in care and achieve viral suppression, which means lower levels of HIV in their blood. These programs have also helped reduce stigma and promote healthy behaviors in Latino communities. Early results suggest this approach could lead to more people achieving viral suppression and fewer emergency room or hospital visits among Latinos with HIV.23567

Are You a Good Fit for This Trial?

This trial is for Latinos with HIV who are struggling to keep the virus under control. Participants will be randomly assigned to receive either a new intervention called ADELANTE, which includes five sessions with a community health worker, or an enhanced care condition involving five reminder phone calls.

Inclusion Criteria

Confirmed HIV infection by standard laboratory results
Receiving HIV primary care at Jackson Memorial Hospital or Thomas Street at Quentin Mease Health Center/Harris Health System
Medical record evidence with last viral load (VL) indicating viral non-suppression (HIV RNA ≥200 cpm) within 90 days of assessment of eligibility
See 2 more

Exclusion Criteria

I am unable to understand and make decisions about my treatment.
Plans to move out of the county in the next 6 months
Currently participating in an HIV intervention study with ongoing follow-up

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive 5 individualized problem-solving sessions delivered by a community health worker over 6 months, framed around a bi-lingual film about HIV

6 months
5 sessions (in-person or virtual)

Enhanced Care Condition

Participants receive 5 locator phone calls confirming contact information and routine HIV health promotion materials

6 months
5 phone calls

Follow-up

Participants are monitored for viral suppression, emergency room visits, and hospitalizations

12 months
Assessments at baseline, month-3, month-6, and month-12

What Are the Treatments Tested in This Trial?

Interventions

  • ADELANTE
Trial Overview The study aims to see if ADELANTE can help participants better manage their HIV and achieve viral suppression compared to those receiving just reminder calls. The success of the program will be measured by checking rates of viral suppression and tracking emergency room visits and hospitalizations over a year.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: ADELANTEExperimental Treatment1 Intervention
Group II: Enhanced Care ConditionActive Control1 Intervention

ADELANTE is already approved in United States for the following indications:

🇺🇸
Approved in United States as ADELANTE for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

Baylor College of Medicine

Collaborator

Trials
1,044
Recruited
6,031,000+

University of Miami

Collaborator

Trials
976
Recruited
423,000+

Published Research Related to This Trial

Community health workers (CHWs) play a crucial role in improving care retention and viral suppression for people living with HIV, but their effectiveness is hindered by unclear roles, inadequate funding, and limited training opportunities.
Key factors for successful CHW integration include establishing standardized roles, fostering interorganizational networks, and providing comprehensive training in areas like trauma-informed care and cultural humility, which can enhance their impact on HIV care outcomes.
Using Implementation Science to Promote Integration and Sustainability of Community Health Workers in the HIV Workforce.Rajabiun, S., Killion, K., Lennon-Dearing, R., et al.[2023]
Community healthcare workers (CHWs) play a crucial role in enhancing HIV services in sub-Saharan Africa by providing support and education, which can improve adherence to treatment and promote safe practices.
This meta-synthesis aims to identify barriers and facilitators affecting CHWs' ability to deliver HIV services, using qualitative evidence from studies conducted between 2009 and 2019, which will help optimize their effectiveness in the region.
Barriers and facilitators of rendering HIV services by community health workers in sub-Saharan Africa: a meta-synthesis protocol.Khumalo, GE., Lutge, E., Naidoo, P., et al.[2021]
Community health worker (CHW) interventions show promise in improving psychosocial outcomes for people living with HIV, particularly in areas like quality of life and self-efficacy, based on a review of 14 randomized controlled trials.
However, these interventions have not been effective in reducing depressive symptoms or stigma related to HIV, indicating a need for future studies to expand their focus and incorporate measures of intervention fidelity.
Community health worker interventions to promote psychosocial outcomes among people living with HIV-A systematic review.Han, HR., Kim, K., Murphy, J., et al.[2019]

Citations

RePORT RePORTER - National Institutes of Health (NIH) |In Aim 1, we will randomize 250 Latinos with HIV in a controlled trial to contrast clinical effectiveness of ADELANTE (5-session, CHW-delivered telenovela-based ...
ADELANTE for HIV · Recruiting Participants ...The goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression.
ADELANTE: a Randomized Controlled Trial to Improve ...The goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression.
High HIV/STI test acceptance through a behavioral health ...Interventions in Latino churches and with community health workers has shown promise in reducing HIV-related stigma and improving intention for HIV testing (78) ...
Community health worker interventions to promote ...The purpose of this study was to critically appraise the types, scope, and nature of CHW interventions designed to address psychosocial outcomes in PLWH.
Project Details - NIH RePORTERIn Aim 1, we will randomize 250 Latinos with HIV in a controlled trial to contrast clinical effectiveness of ADELANTE (5-session, CHW-delivered telenovela-based ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security